Incidence of steroid-induced diabetes mellitus among in-patients treated for COVID-19 infection in tertiary care centre
DOI:
https://doi.org/10.18203/2320-6012.ijrms20231341Keywords:
COVID-19, Diabetes mellitus, Glucocorticoids, Glucocorticoid-induced diabetes mellitus, Hyperglycaemia, SARS-CoV-2Abstract
Background: Glucocorticoids are one of the most effective lifesaving treatments for severe COVID-19 infection. The aim of this study was to review the incidence of glucocorticoid-induced diabetes and its associated risk factors in COVID-19 patients.
Methods: This was a retrospective cohort study, Hassan institute of medical sciences, Hassan, Karnataka, from 1st July 2020 to 31st December 2021. Data were collected from the medical record department of all RTPCR/RAT-positive cases of COVID-19 patients admitted and treated for COVID-19, with a sample size of 521 patients.
Results: In the present study of 521 patients with COVID-19 who received glucocorticoid therapy, 72 (13.8%) of the patients experienced GI-DM. In our series of 521 patients treated with steroid for respiratory diseases, old age and chronic smoking was an independent risk factor for GI-DM. Glucose tolerance declines progressively with age, resulting in a high incidence of type 2 diabetes and impaired glucose tolerance in the old population.
Conclusions: In conclusion, this study found that 13.8% of in-patients treated for COVID-19 infection in a tertiary care centre developed GI-DM. The incidence of GI-DM was higher among patients who were older, had a history of smoking, and had hyperlipidaemia or malignancy. The study highlights the importance of monitoring blood glucose levels in patients receiving steroids for the treatment of COVID-19. Additionally, the results suggest that patients with certain risk factors may benefit from closer monitoring of blood glucose levels.
Metrics
References
De Bosscher K, Vanden Berghe W, Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunology 2000; 109: 16-22
Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. endocr pract 2009; 15: 469-74.
Swafe L, Narwani V, Stavraka C, Dhatariya K. How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoids Clin med 2014;14:327-8.
D M Nathan, S Genuth, J Lachin, P Cleary. The diabetes control and complications trial research group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
Tryfon S, Papanas N. Corticosteroid-induced diabetes in patients with chronic obstructive pulmonary disease. Clin Pulm Med 2008; 15: 127- 31.
Stoudt K, Chawla S. Don’t sugar coat it: glycemic control in the intensive care unit. J Intensive Care Med. 2019;34:889- 896.
Tamez-Perez HE, Quintanilla-Flores DL, RodriguezGutierrez R, Gonzalez-Gonzalez JG, Tamez-Pena AL. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6:1073-1081.
Cheung NW. Steroid-induced hyperglycaemia in hospitalised patients: does it matter 2016;59:2507–2509
Liu XX, Zhu XM, Miao Q, Ye HY, Zhang ZY, Li YM. Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab 2014;65:324–332
Bornstein SR, Rubino F, Khunti K, et al.. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet diabetes endocrinology 2020;8:546–550
Accili D. Can COVID-19 cause diabetes? Nature Metabolism [Internet]. 2021 Jan 11 [cited 2023 Jan 30];1–3.
Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009. 15:469–474.
Tryfon S, Papanas N. Corticosteroid-induced diabetes in patients with chronic obstructive pulmonary disease. Clin Pulm Med. 2008. 15:127–131.
Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002. 25:583–592.
Panthakalam S, Bhatnagar D, Klimiuk P. The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy. Scott Med J. 2004. 49:139–141.
Smyllie HC, Connolly CK. Incidence of serious complications of corticosteroid therapy in respiratory disease. A retrospective survey of patients in the Brompton hospital. Thorax. 1968. 23:571–581.
Uzu T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A, Yamauchi A. Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Nephron Clin Pract. 2007. 105:c54–c57.
Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Kojima M. Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases. Pharmacotherapy. 2004. 24:508–514.
Raúl Ariza-Andraca C, Barile-Fabris LA, Frati-Munari AC, Baltazár-Montufar P. Risk factors for steroid diabetes in rheumatic patients. Arch Med Res. 1998. 29:259–262.
Arner P, Gunnarsson R, Blomdahl S, Groth CG. Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care. 1983. 6:23–25.
Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Järvinen H, Ferrannini E. Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab. 1999. 84:863–868.
Kim SG, Yang SW, Choi SI, Park SH, Lee KR, Park JH, Jang AS, Seo JP, Lee S, Nam HS, Sun MH, Shin MG, Chung DJ, Chung MY. Prevalence of diabetes mellitus in the elderly of Namwon county, South Korea. Korean J Med. 2001. 60:555–566.
Korean National Health and Nutrition Examination Survey. 2008. accessed on 13 Jan 2023. Available at http://knhanes.cdc.go.kr.
Thearle M, Brillantes AM. Unique characteristics of the geriatric diabetic population and the role for therapeutic strategies that enhance glucagon-like peptide-1 activity. Curr Opin Clin Nutr Metab Care. 2005. 8:9–16.
18. Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab. 2003. 284:E7–E12.
Downloads
Published
How to Cite
Issue
Section
